Growing Trend of Minimally Invasive Cardiac Output Monitoring to Accelerate Market Growth
Technological advancements have enabled continuous real-time cardiac output (CO) monitoring in lithium dilution technique. This technique is projected to witness exponential growth in the cardiac output monitoring devices market during the forecast period. Lithium dilution (LiD) is known to exhibit good correlation with the pulmonary artery catheter (PAC) thermodilution technique in hyperdynamic conditions. This trend has helped manufacturers in the cardiac output monitoring devices market to leverage opportunities in lithium dilution and PAC thermodilution technique. Thus, LiDCOplus technology is being used as a reliable substitute for more invasive PAC thermodilution methods.
The trend of minimally invasive cardiac output monitoring (MICOM) devices is triggering growth for the cardiac output monitoring devices market. Improvements in the cardiac output monitoring devices market landscape has led to innovations in less-invasive Doppler ultrasound.
Request Sample Of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14153
To know the scope of our report Get a Sample on Cardiac Output Monitoring Devices Market
Rising Adoption of Transthoracic Impedance & Bioreactance Analysis Technology
The cardiac output monitoring devices market is witnessing increasing adoption of less-invasive methods for measuring stroke volume (SV) and CO in patients. Transthoracic electrical bioimpedance (TEB) and Doppler echocardiography (transthoracic echocardiography) are both non-invasive methods used for the measurement of SV and CO. Though invasive devices hold the highest revenue in the cardiac output monitoring devices market, a high number of healthcare providers are opting for non-invasive methods to improve patient life quality.
Get a glimpse of the in-depth analysis through our Report Brochure
TEB is increasingly gaining popularity among healthcare providers to offer continuous estimates on SV, whereas transthoracic echocardiography (TTE) is being used for intermittent image-based estimates. As such, TTE is an important technique in transthoracic impedance & bioreactance analysis. Thus, the transthoracic impedance & bioreactance analysis segment holds a higher value as compared to the Doppler segment in the cardiac output monitoring devices market, with the former expected to reach a value of ~US$ 200 Mn by 2027. This can be attributed to increased adoption of TTE in cardiac functional assessment, especially in critical care. Hence, manufacturers in the cardiac output monitoring devices market are increasing their efficacy to develop advanced devices involving TEB and TTE.
Deep Learning to Help Overcome Limitations of Arterial Waveform Analysis Technique
There is a growing need for innovative methods to assess flow-based hemodynamic parameters, such as SV, in patients. Healthcare providers in the cardiac output monitoring devices market landscape are increasing efforts to assess SV in patients, since SV provides important insights into systemic oxygen delivery and global tissue perfusion.
The arterial waveform analysis technique is gaining importance as a non-invasive and commercially available method to assess SV. As such, the technique is estimated for an exponential growth and this technology segment of the cardiac output monitoring devices market is expected to reach a value of ~US$ 300 Mn by 2027. Insights into this novel technique has enabled healthcare providers operating in the cardiac output monitoring devices market to optimize diagnostic and treatment strategies.
However, several concerns regarding this technique such as the need for manual calibration and unreliable estimation of the hemodynamic profile, act as key restraints for device manufacturers. Hence, healthcare companies in the cardiac monitoring devices market are adopting the technology of deep learning (DL) to overcome the limitations of the arterial waveform analysis technique.
Lithium Dilution and Pulse Contour CO Gain Popularity as Non-invasive Treatment Methods
Cardiac output (CO) is a vital physiological surrogate parameter, addressing the comprehensive hemodynamic profile of patients. Moreover, healthcare providers in the cardiac output monitoring devices market landscape are diversifying the application of CO measurement for athletes. This trend is creating incremental opportunities for both healthcare providers as well as companies in the cardiac monitoring devices market.
Catheter-based measuring is a clinically-approved standard for CO measurement. As such, PAC is estimated to account for the highest revenue amongst all technologies in the cardiac output monitoring devices market. The segment is projected to reach a value of ~US$ 600 Mn by 2027. However, catheter-based measuring is an invasive method, which is associated with high risks of morbidity and mortality in patients.
Additionally, the use of PAC is restricted only to certain medical procedures. Hence, manufacturers in the cardiac output monitoring devices market are increasing production capabilities of consumables and devices for lithium dilution technique and thermodilution pulse contour analysis. Growing awareness about non-invasive methods among patients has accelerated the growth of the two segments.
Expanding operations in future? To get the perfect launch ask for a custom report
More Trending Reports by Transparency Market Research – https://www.biospace.com/article/anal-irrigation-systems-market-manufacturers-devise-process-assessments-for-safety-of-new-product-offerings/
No comments:
Post a Comment